Figure 1
From: Endocan as a marker of microvascular inflammation in kidney transplant recipients
Endocan levels according to renal allograft status. (A) Plasma endocan levels were significantly higher in patients with acute ABMR than those in patients with NP, ATN, APN, BKVN, and TCMR. Patients with chronic active ABMR exhibited significantly higher plasma endocan levels than patients with LTGS. (B) Similar to plasma endocan levels, urinary endocan levels were significantly increased in patients with acute ABMR compared to those in the other groups in the short transplant vintage set. Patients with TCMR exhibited higher urinary endocan levels than patients with NP, and the levels were also higher in patients with chronic active ABMR than in patients with LTGS. *p < 0.05, **p < 0.005. Abbreviations: NP, normal pathology; ATN, acute tubular necrosis; APN, acute pyelonephritis; BKVN, BK virus associated nephropathy; TCMR, T-cell mediated rejection; aABMR, acute antibody-mediated rejection; LTGS, long-term graft survival; cABMR, chronic active antibody-mediated rejection.
